Osteopore Ltd News

Osteopore Raises AU$23,312 Following Exercise of Options

Osteopore (ASX:OSX) raised AU$23,312 via the issue of 602,524 ordinary shares upon the exercise of unquoted options exercisable at AU$0.0387 per option, according to a Thursday filing with the Austral

MT NewswiresMay 23 03:43 ET

Osteopore Ltd. Raises Funds Through Share Issuance

TipRanksMay 22 22:08 ET

Osteopore Ltd Expands Securities Portfolio

TipRanksMay 22 22:08 ET

Osteopore Ltd. Appoints New Company Secretary

TipRanksMay 20 04:27 ET

Osteopore Ltd. Announces Shift in Major Holdings

TipRanksMay 19 23:27 ET

Advance Opportunities Fund Takes Stake in Osteopore Ltd

TipRanksMay 17 03:57 ET

Osteopore Partners SingHealth to Establish Global Center of Excellence; Shares Surge 22%

Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX) partnered with SingHealth, under the auspices of the Alice Lee Innovation Centre of Excellence at Singapore General Hospital Ca

MT NewswiresMay 13 22:04 ET

Osteopore Ltd. Issues New Unlisted Options

TipRanksMay 7 22:47 ET

Osteopore Ltd. Completes Successful Capital Raise

TipRanksMay 7 05:27 ET

Osteopore Ltd. Hits Record Revenue Growth

TipRanksApr 29 22:38 ET

Osteopore Ltd. Announces Upcoming AGM Date

TipRanksApr 29 00:57 ET

Australian Shares Rise on Business Activity Growth; Osteopore Soars 127%

Australian shares rose on Tuesday's close of trading as business activity grew to its quickest pace in over 24 months in April. The S&P/ASX200 Index rose 0.45% or 34.3 points to close at 7,683.5. Inve

MT NewswiresApr 23 02:34 ET

Osteopore Ltd. Addresses ASX Trading Query

TipRanksApr 22 23:08 ET

Osteopore Ltd Requests Immediate Trading Halt

TipRanksApr 22 22:57 ET

Osteopore Commences In-Human Clinical Trials for Knee Preservation; Shares Surge 194%

Regenerative medicine company Osteopore (ASX:OSX) commenced its first in-human clinical trials for knee preservation in Singapore, according to a Tuesday filing with the Australian Securities Exchange

MT NewswiresApr 22 21:50 ET

Stocks of the Hour: Osteopore, Augustus Minerals, Tamboran Resources

Global leader in 3D-printed biomimetic and bioresorbable implants, Osteopore (ASX:OSX) announced the successful commencement of first-in-human clinical trials for knee preservation in Singapore. The s

sharecafeApr 22 21:43 ET

Osteopore Ltd. Demonstrates Strong Governance

TipRanksApr 16 05:07 ET

Osteopore Ltd. Confirms Delay Amidst Compliance

TipRanksApr 14 23:37 ET

Osteopore Secures Extension for Bridging Loan Maturity

Regenerative medicine company Osteopore (ASX:OSX) secured a maturity date extension for its SG$1 million bridging loan with Advance Opportunities Fund I to May 1, 2025. The interest rate for the loan

MT NewswiresApr 10 04:08 ET

Osteopore Ltd. Enhances Loan Terms, Bolsters Capital

TipRanksApr 10 02:07 ET